A public-private partnership between ARPA-H and VentureWell in support of the ARPANET-H nationwide health innovation network. Website is maintained by VentureWell staff.
ARPA-H Program Manager Calvin Roberts, M.D., will join the Investor Catalyst Hub’s virtual monthly meeting on Wednesday, December 4, noon ET to discuss ARPA-H’s new Ocular Laboratory for Analysis of Biomarkers (OCULAB) program. OCULAB seeks to develop a tear-based biomarker measurement system that can be inserted into the tear duct for continuous health monitoring and provide ultra-precise medication dosing for personalized treatment via a closed-loop delivery system.
Don’t miss this opportunity to learn more about OCULAB and to connect with Dr. Roberts live during a Q&A session.